Abstract
There is strong evidence that UV irradiation is a causal factor in human nonmelanoma skin cancer (1β3), and that immunosuppression is a high risk factor for skin cancer in humans (4,5). The use of animal model systems to investigate the sequence of events which lead to the induction and progression of skin tumors following chronic ultraviolet irradiation has clearly shown that the genotoxic effect of UV irradiation is only one of the components involved in this process. Immunological factors are also critically important in the pathogenesis of UV induced skin cancers (6,7). Most tumors induced by UV irradiation are highly antigenic and cannot grow in normal syngeneic mice. However, they can grow in immunodepressed or UV irradiated mice. The inability to reject antigenic, syngeneic UV-induced tumors can be transferred from UV irradiated mice to naive recipients with splenocytes bearing an Lyt-1+, Lyt-2β, L3T4+, Iaβ, henotype(8). This anergy has been found to be critical in photocarcinogenesis (9). Significantly, the suppression induced by UV irradiation appears to be restricted to contact hypersensitivity reactions and rejection of tumors induced by UV radiation or some chemicals (10,11). Antibody formation, mitogen reactivity, and allograft rejection are reported to be normal in UV irradiated mice (12β14).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Engel, A., Johnson, M.L. and Haynes, S.G. Health effects of sunlight exposure in the United States. Arch. Dermatol. 124:72β79, 1988.
Forbes, P.D. and Davies, R.E. Photobiology of experimental ultraviolet photocarcinogenesis. In: R.W. Daynes and J.D. Spikes, (eds.), Experimental and Clinical Photoimmunology Vol. 1, pp. 43β60. Boca Raton, Florida: CRC Press, 1986.
Kraemer, K.H., Lee, M.M. and Scotto, J. Xeroderma pigmentosum, cutaneous, ocular, and neurologic abnormalities in 830 published cases. Arch. Dermatol., 123:241β250, 1987.
Sheil, A.G. Cancer after transplantation. World J. Surg. 10:389β396, 1986.
Penn, I. Cancer is a complication of severe immunosuppression. Surg. Gynecol. Obst., 162:603β610, 1986.
Kripke, M.L. Immunological unresponsiveness induced by ultraviolet radiation. Immunol. Rev. 80:87β102, 1984.
Daynes, R.A., Bernhard, E.J., Gurish, M.F. and Lynch, D.H. Experimental photoimmunology: Immunologic ramifications of UV-induced carcinogenesis. J. Invest. Dermatol., 77:77β85,1981.
Ullrich, S.E. and Kripke, M.L. Mechanisms in the suppression of tumor rejection produced in mice by repeated UV irradiation. J.immunol., 133:2786β2790, 1984.
Fisher, M.S. and Kripke, M.L. Suppressor T lymphocytes control the development of primary skin cancers in ultraviolet-irradiated mice. Science, 216:1133β1134, 1982.
Noonan, F.P., Kripke, M.L., Pedersen, G.M., and Greene, M.I. Suppression of contact hypersensitivity in mice by ultraviolet irradiation is associated with defective antigen presentation. Immunology, 43:527β533, 1981.
Roberts, L.K., and Daynes, R.A. Modification of the immunogenic properties of chemically induced tumors arising in hosts treated concomitantly with ultraviolet light. J. Immunol. 125:438β447, 1980.
Spellman, C.W., Woodward, J.G., and Daynes, R.A. Modification of immunolgical potential by ultraviolet radiation. I. Immune status of short term UV-irradiated mice. Transplantation 24:112β119, 1977.
Kripke, M.L., Lofgreen, J.S., Beard, J., Jessup, JM., and Fisher, M.S. In vivo immune response of mice during carcinogenesis by ultraviolet irradiation. J. Natl. Cancer Inst., 59:1227β1230, 1977.
Norbury, K.C., Kripke, M.L., and Budman, M.B. In vitro reactivity of macrophages and lymphocytes from ultraviolet-irradiated mice. J. Natl. Cancer Inst., 59:1231β1235, 1977.
Connor, M.J., Lowe, N.J., Breeding, J.H. and Chalet, M. Inhibition of ultraviolet-B skin carcinogenesis by all-trans-retinoic acid regimens that inhibit ornithine decarboxylase induction. Cancer Res., 43:171β174, 1983.
Epstein, J.H. and Grekin, D.A. Inhibition of ultraviolet induced carcinogenesis by all-transretinoic acid. J. Invest. Dermatol., 76:178β180, 1981.
Boutwell, R.K., Verma, A.K., Takigawa, M., Loprinzi, C.L. and Carbone, P.P. Retinoids as inhibitors of tumor promotion. In: J.H. Saurat, (ed.) Retinoids: New Trends in Research and Therapy pp. 83β96. Basel, Karger, 1985.
Gensler, H.L., Watson, R.R., Moriguchi, S. and Bowden, G.T. Effects of dietary retinyl palmitate or 13-cisretinoic acid on the promotion of tumors in mouse skin. Cancer Res., 47:967β970, 1987.
Gensler, H.L., Sim, D.A. and Bowden, G.T. (1986) Influence of the duration of topical 13-cis-retinoi acid treatment on inhibition of mouse skin tumor promotion. Cancer Res., 46:2767β2770, 1986.
Malkovsky, M., Hunt, R., Palmer, L., Dore, C. and Medawar, P.B. Retinyl acetate-mediated augmentation of resistance to a transplantable 3-methylcholanthreneinduced fibrosarcoma. Transplantation, 38:158β161, 1984.
Cohen, B.E., Gill, G., Cullen, P.R., and Morris, P.J. Reversal of postoperative immunosuppression in man by vitamin A. Surg. Gynecol. Obstet., 149:658β662, 1979.
Fusi, S., Kupper, T.S., Green, JD.R., and Ariyan, S. Reversal of postburn immunosuppression by the administration of vitamin A. Surgery, 96:330β334, 1984.
Mathews-Roth, M.M. and Krinsky, N.I. Carotenoid dose level and protection against UV-B induced skin tumors. Photochem. Photobiol. 42:35β38, 1985.
Bendich, A. and Shapiro, S.S. Effect of Ξ²- carotene and canthaxanthin on the immune responses of the rat. J. Nutr. 116:2254β2262, 1986.
Peng, Y.M., Alberts, D.S., Xu, M.J., Watson, R.R., Gensler, H.L. and Bowden, G.T. Effects of high dietary retinyl palmitate and selenium on tissue distribution of retinoids in mice exposed to tumor initiation and promotion. J. Nutr. Growth Cancer, 3:38β45, 1986.
Gensler, H.L. Reduction of immunosuppression in UV-irradiated mice by dietary retinyl palmitate plus canthaxanthin. Carcinogenesis, 10:203β207, 1989.
Dennert, G., Crowley, C., Kouba, J. and Lotan, R. Retinoic acid stimulation of the induction of mouse killer T-cells in allogeneic and syngeneic systems. J. Natl. Cancer Inst., 62:89β94, 1979.
Colizzi, V. and Malkovsky, M. Augmentation of interleukin-2 production and delayed hypersensitivity in mice infected with Mycobacterium bovis and fed a diet suppplemented with vitamin A acetate. Infect. Immun., 48:581β583, 1985.
Dennert, G. Immunostimulation by retinoic acid. In: J. Nugent, and S. Clark, S. (eds), Retinoids, Differentiation and Disease Ciba Foundation Symposium 113, pp. 117β131. London: Pitman, 1985.
Watson, R.R., Moriguchi, S. and Gensler, H.L. Effects of dietary retinyl palmitate and selenium on tumoricidal capacity of macrophages in mice undergoing tumor promotion. Cancer Lett., 36:181β187, 1987.
Krinsky, N.I. and Deneke, S.M. Interaction of oxygen and oxyradicals with carotenoids. J. Natl. Cancer Inst., 69:205β210, 1982.
Sprangrude, G.J. and Daynes, R.A. Oxygenated sterols as immunosuppressive agents. In: R.A. Daynes and G. Krueger (eds), Experimental and Clinical Photoimmunology Vol.II, pp. 89β102. Boca Raton, Florida, CRC Press, 1986.
Rigby, W.F. The immunobiology of vitamin D. Immunol. Today, 9:54β62, 1988.
Klein, G. Tumor antigens. Annu. Rev. Microbiol. 20:223β252, 1966.
Hellstrom, D.E. and Hellstrom, I. Cellular immunity against tumor antigens. Adv. Cancer Res. 12:167β223, 1969.
Hostetler, L.W., Romerdahl, C.A. and Kripke, M.L. Specificity of antigens on UV radiation-induced antigenic tumor cell variants measured in vitro and in vivo. Cancer Res., 49:1207β1213, 1989.
North, R.J. and Dye, E.S. Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells. Immunology, 53:47β56, 1985.
North, R.J. and Bursuker, I. The generation and decay of the immune response to a progressive fibrosarcoma: Ly-1+2- suppressor T cells down-regulate the generation of Ly-1-2+ effector T cells. J. Exp. Med., 159:1295β1311, 1984.
Dye, E.S. and North, R.J. Specificity of the T cells that mediate and suppress adoptive immunotherapy of established tumors. J. Leukocyte Biol., 36:27β38, 1984.
DiGiacomo, A. and North, R.J. T cell suppressors of antitumor immunity. The production of Ly-1-2+ suppressors of delayed sensitivity precedes the production of suppressors of protective immunity. J. Exp. Med., 164:1179β1192, 1986.
Kripke, M.L., and Fisher, M.S. Immunologic parameters of ultraviolet carcinogenesis. J. Natl. Cancer Inst., 57:211β215, 1976.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
Β© 1990 The Humana Press Inc.
About this chapter
Cite this chapter
Gensler, H.L. (1990). Reduction of Ultraviolet-Induced Immunosuppression and Enhanced Resistance to Ultraviolet-Induced Tumors by Retinyl Palmitate and Canthaxanthin. In: Prasad, K.N., Meyskens, F.L. (eds) Nutrients and Cancer Prevention. Experimental Biology and Medicine, vol 23. Humana Press. https://doi.org/10.1007/978-1-4612-4516-2_12
Download citation
DOI: https://doi.org/10.1007/978-1-4612-4516-2_12
Publisher Name: Humana Press
Print ISBN: 978-1-4612-8856-5
Online ISBN: 978-1-4612-4516-2
eBook Packages: Springer Book Archive